newsfilter
← Latest News
GlobeNewswire·

Pardes Biosciences Appoints Thomas G. Wiggans to CEO and Chairman of the Board

Mr. Wiggans brings over 40 years of biopharmaceutical industry experience, including over 25 years in chief executive leadership roles with multiple successful acquisitions. His expertise will be beneficial to Pardes as the company rapidly progresses to